Diabetes, Vol 49, Issue 12 2170-2177, Copyright © 2000 by American Diabetes Association

ARTICLES

Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy

A Ceriello, A Morocutti, F Mercuri, L Quagliaro, M Moro, G Damante and GC Viberti
Department of Pathology and Medicine, Experimental and Clinical, University of Udine, Italy. antonio.ceriello@dpmsc.uniud.it

There is an individual susceptibility to diabetic nephropathy, and oxidative stress is believed to play an important role in the pathogenesis of diabetic complications. Active oxygen species induce antioxidant enzyme expression in tissues, an effect considered to be a defensive mechanism. To test whether altered intracellular antioxidant enzyme production might explain the predisposition to diabetic nephropathy, we studied the effect of long-term (12 weeks) exposure to normal (5 mmol/l) or high (22 mmol/l) glucose concentrations on fibroblast antioxidant enzyme gene expression and protein activity in type 1 diabetic patients with and without nephropathy, nondiabetic nephropathic patients, and nondiabetic control subjects. Under conditions of normal glucose concentration in the culture media, CuZnSuperoxide-dismutase, MnSuperoxide-dismutase, catalase, and glutathione-peroxidase activity and mRNA expression were not different among the four groups. Under high-glucose conditions, CuZnSuperoxide-dismutase mRNA and activity increased similarly in all groups (P < 0.001 vs. basal), whereas MnSuperoxide-dismutase did not change. In contrast, catalase mRNA and activity as well as glutathione-peroxidase mRNA and activity increased in fibroblasts from type 1 diabetic patients without nephropathy (P < 0.001), in fibroblasts from nondiabetic nephropathic patients (P < 0.001), and in fibroblasts from nondiabetic control subjects (P < 0.001), but not in fibroblasts from type 1 diabetic patients with nephropathy. Exposure to high glucose concentrations significantly increased lipid peroxidation in cells, higher levels being found in cells from diabetic patients with nephropathy (P < 0.001). These data, while confirming that exposure to high glucose concentrations induces an antioxidant defense in skin fibroblasts from normal subjects, demonstrate a failure of this defensive mechanism in cells from type 1 diabetic patients with nephropathy, whereas skin fibroblasts from diabetic patients without complications or from nondiabetic nephropathic patients have an intact antioxidant response to glucose-induced oxidative stress.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M. Forbes, M. T. Coughlan, and M. E. Cooper Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes Diabetes, June 1, 2008; 57(6): 1446 - 1454. [Abstract] [Full Text] [PDF]

				A. Ceriello, K. Esposito, L. Piconi, M. A. Ihnat, J. E. Thorpe, R. Testa, M. Boemi, and D. Giugliano Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients Diabetes, May 1, 2008; 57(5): 1349 - 1354. [Abstract] [Full Text] [PDF]

				M. Liang and J. L. Pietrusz Thiol-Related Genes in Diabetic Complications: A Novel Protective Role for Endogenous Thioredoxin 2 Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 77 - 83. [Abstract] [Full Text] [PDF]

				M. L. Caramori, Y. Kim, P. Fioretto, C. Huang, S. S. Rich, M. E. Miller, G. B. Russell, and M. Mauer Cellular basis of diabetic nephropathy: IV Antioxidant enzyme mRNA expression levels in skin fibroblasts of type 1 diabetic sibling pairs Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3122 - 3126. [Abstract] [Full Text] [PDF]

				L. Puricelli, E. Iori, R. Millioni, G. Arrigoni, P. James, M. Vedovato, and P. Tessari Proteome Analysis of Cultured Fibroblasts from Type 1 Diabetic Patients and Normal Subjects J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3507 - 3514. [Abstract] [Full Text] [PDF]

				C. Huang, Y. Kim, M. L. Caramori, J. H. Moore, S. S. Rich, J. C. Mychaleckyj, P. C. Walker, and M. Mauer Diabetic Nephropathy Is Associated With Gene Expression Levels of Oxidative Phosphorylation and Related Pathways Diabetes, June 1, 2006; 55(6): 1826 - 1831. [Abstract] [Full Text] [PDF]

				A. Rosso, A. Balsamo, R. Gambino, P. Dentelli, R. Falcioni, M. Cassader, L. Pegoraro, G. Pagano, and M. F. Brizzi p53 Mediates the Accelerated Onset of Senescence of Endothelial Progenitor Cells in Diabetes J. Biol. Chem., February 17, 2006; 281(7): 4339 - 4347. [Abstract] [Full Text] [PDF]

				K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]

				Y. Xu, B. W. Osborne, and R. C. Stanton Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1040 - F1047. [Abstract] [Full Text] [PDF]

				F. Chiarelli, D. Di Marzio, F. Santilli, A. Mohn, A. Blasetti, F. Cipollone, A. Mezzetti, and A. Verrotti Effects of Irbesartan on Intracellular Antioxidant Enzyme Expression and Activity in Adolescents and Young Adults With Early Diabetic Angiopathy Diabetes Care, July 1, 2005; 28(7): 1690 - 1697. [Abstract] [Full Text] [PDF]

				J. Morrison, K. Knoll, M. J. Hessner, and M. Liang Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response Physiol Genomics, May 19, 2004; 17(3): 271 - 282. [Abstract] [Full Text] [PDF]

				F. R. DANESH and Y. S. KANWAR Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy FASEB J, May 1, 2004; 18(7): 805 - 815. [Abstract] [Full Text] [PDF]

				A. Ceriello and E. Motz Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 816 - 823. [Abstract] [Full Text]

				S. Salardi, S. Zucchini, D. Elleri, G. Grossi, A. M. Bargossi, S. Gualandi, R. Santoni, A. Cicognani, and E. Cacciari High Glucose Levels Induce an Increase in Membrane Antioxidants, in Terms of Vitamin E and Coenzyme Q10, in Children and Adolescents With Type 1 Diabetes Diabetes Care, February 1, 2004; 27(2): 630 - 631. [Full Text] [PDF]

				A. D. Hodgkinson, B. A. Millward, and A. G. Demaine Association of the p22phox Component of NAD(P)H Oxidase With Susceptibility to Diabetic Nephropathy in Patients With Type 1 Diabetes Diabetes Care, November 1, 2003; 26(11): 3111 - 3115. [Abstract] [Full Text] [PDF]

				A. Ceriello New Insights on Oxidative Stress and Diabetic Complications May Lead to a "Causal" Antioxidant Therapy Diabetes Care, May 1, 2003; 26(5): 1589 - 1596. [Abstract] [Full Text] [PDF]

				A. D. Hodgkinson, T. Bartlett, P. J. Oates, B. A. Millward, and A. G. Demaine The Response of Antioxidant Genes to Hyperglycemia Is Abnormal in Patients With Type 1 Diabetes and Diabetic Nephropathy Diabetes, March 1, 2003; 52(3): 846 - 851. [Abstract] [Full Text] [PDF]

				R. P. Blankfield, A. Ceriello, E. Motz, M. Walser, E. J. Lewis, B. M. Brenner, the RENAAL Study Investigators, H.-H. Parving, and the Irbesartan in Patients with Type 2 Diabetes an Angiotensin-Receptor Blockers, Type 2 Diabetes, and Renoprotection N. Engl. J. Med., February 28, 2002; 346(9): 705 - 707. [Full Text] [PDF]

				A. Fornoni, L. J. Striker, F. Zheng, and G. E. Striker Reversibility of Glucose-Induced Changes in Mesangial Cell Extracellular Matrix Depends on the Genetic Background Diabetes, February 1, 2002; 51(2): 499 - 505. [Abstract] [Full Text] [PDF]